Our Science Diverse Biotech

Conjugate Synthesis Platform

How our new drug works, compared to standard therapy: Targeting Brain Cancer.

Traditional approach
(The old way)
Drug 1
Drug 2

Drug 1 Drug 2 follow their own independent patterns and high toxicity applies throughout the body.

Drug 1 doesn’t always make it to the same site Drug 2 makes it to.

New conjugate approach
(The New Way)
Drug 1 +2

Drug 2 is released at the site of Drug 1 action Drug 1 & 2 are always present at the same site.

Conjugate is less toxic than Drug 1 & 2 alone. Toxic action is only at site of cancer being present.

The New Way

Specific Advantages of Conjugate Platform

Click and learn more

Step increase in efficacy

  • Rapid absorption and distribution
  • Increased lipophilicity (cross blood–brain barrier)
  • Effective to >10x the current standard of care
  • Potential to lower dose of current highly-toxic therapeutic agents in the market today

Improved tolerability for patients

  • Decreased toxicity
  • IFewer side effects

Multiple Functionality

  • Patented across many drug families or classes in multiple disease state
  • Patent extension on existing drugs
  • Significantly ‘de-risking’ Drug Discovery with studied entities